Tumor necrosis factor-based isolated limb perfusion for soft tissue sarcoma and melanoma: Ten years of successful antivascular therapy Alexander M. M. EggermontTimo L. M. ten Hagen Invited Commentary Pages: 79 - 80
Pegylated interferon alfa-2b as treatment of solid tumors Ronald M. Bukowski Clinical Trials Report Pages: 87 - 88
Tubulin interacting agents: Novel taxanes and epothilones Neeraj R. AgrawalRam GanapathiTarek Mekhail OriginalPaper Pages: 89 - 98
Preclinical and clinical evaluation of farnesyltransferase inhibitors Charles BaumPaul Kirschmeier OriginalPaper Pages: 99 - 107
New and modified interferon alfas: Preclinical and clinical data Paul MasciRonald M. BukowskiErnest C. Borden OriginalPaper Pages: 108 - 113
Postoperative concurrent radiation and chemotherapy for squamous cell carcinoma of the head and neck Ehab Y. Hanna Clinical Trials Report Pages: 129 - 130
Intensity-modulated radiotherapy for carcinoma of the head and neck José A. PeñagarícanoNiko Papanikolaou OriginalPaper Pages: 131 - 139
The role of epidermal growth factor receptor in head and neck squamous cell carcinoma Rebecca G. PomerantzJennifer Rubin Grandis OriginalPaper Pages: 140 - 146
The skull base, paranasal sinuses, and related malignancies Chad A. ZenderGuy J. Petruzzelli OriginalPaper Pages: 147 - 151
Chemoprevention of head and neck cancer Katrina Y. GloverVali A. Papadimitrakopoulou OriginalPaper Pages: 152 - 157
Stereotactic radiosurgery for patients with cancer of the head and neck Edward GardnerMark E. LinskeyEhab Y. Hanna OriginalPaper Pages: 164 - 169